These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17763342)

  • 41. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
    Kuwatsuru R; Brasch RC; Mühler A; Mathur A; Vexler VS; Rosenau W; Mintorovitch J; Berthezene Y; Cohen F; Shames DM
    Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI detection of macrophages labeled using micrometer-sized iron oxide particles.
    Williams JB; Ye Q; Hitchens TK; Kaufman CL; Ho C
    J Magn Reson Imaging; 2007 Jun; 25(6):1210-8. PubMed ID: 17520727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of ferumoxides-protamine sulfate labeling on immunomodulatory characteristics of macrophage-like THP-1 cells.
    Janic B; Iskander AS; Rad AM; Soltanian-Zadeh H; Arbab AS
    PLoS One; 2008 Jun; 3(6):e2499. PubMed ID: 18575575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Positive contrast in the detection of magnetically labeled cells by MRI--in vitro experiments].
    Pintaske J; Martirosian P; Claussen CD; Schick F
    Biomed Tech (Berl); 2005 Sep; 50(9):271-6. PubMed ID: 16185035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.
    Kim SH; Choi D; Lim JH; Lee WJ; Jang HJ; Lim HK; Lee SJ; Cho JM; Kim SK; Kim GC
    Korean J Radiol; 2002; 3(2):87-97. PubMed ID: 12087198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
    Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
    J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering.
    Terrovitis JV; Bulte JW; Sarvananthan S; Crowe LA; Sarathchandra P; Batten P; Sachlos E; Chester AH; Czernuszka JT; Firmin DN; Taylor PM; Yacoub MH
    Tissue Eng; 2006 Oct; 12(10):2765-75. PubMed ID: 17518646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors.
    Taschner CA; Wetzel SG; Tolnay M; Froehlich J; Merlo A; Radue EW
    AJR Am J Roentgenol; 2005 Dec; 185(6):1477-86. PubMed ID: 16304001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques.
    Arbab AS; Bashaw LA; Miller BR; Jordan EK; Bulte JW; Frank JA
    Transplantation; 2003 Oct; 76(7):1123-30. PubMed ID: 14557764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology.
    Kim J; Kim DI; Lee SK; Kim DJ; Lee JE; Ahn SK
    Acta Radiol; 2008 Jun; 49(5):580-8. PubMed ID: 18568546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR lymphography with iron oxide compound AMI-227: studies in ferrets with filariasis.
    Tanoura T; Bernas M; Darkazanli A; Elam E; Unger E; Witte MH; Green A
    AJR Am J Roentgenol; 1992 Oct; 159(4):875-81. PubMed ID: 1529857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
    Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
    PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting of hematopoietic progenitor cells with MR contrast agents.
    Daldrup-Link HE; Rudelius M; Oostendorp RA; Settles M; Piontek G; Metz S; Rosenbrock H; Keller U; Heinzmann U; Rummeny EJ; Schlegel J; Link TM
    Radiology; 2003 Sep; 228(3):760-7. PubMed ID: 12881578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.
    Tanimoto A; Wakabayashi G; Shinmoto H; Okuda S; Kuribayashi S; Mukai M
    J Magn Reson Imaging; 2005 Mar; 21(3):230-6. PubMed ID: 15723373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.